• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死合并心源性休克患者接受经皮冠状动脉介入治疗的时间趋势和结局:来自心脏导管介入注册研究的报告

Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry.

作者信息

Wayangankar Siddharth A, Bangalore Sripal, McCoy Lisa A, Jneid Hani, Latif Faisal, Karrowni Wassef, Charitakis Konstantinos, Feldman Dmitriy N, Dakik Habib A, Mauri Laura, Peterson Eric D, Messenger John, Roe Mathew, Mukherjee Debabrata, Klein Andrew

机构信息

Cleveland Clinic, Cleveland, Ohio.

New York University School of Medicine, New York, New York.

出版信息

JACC Cardiovasc Interv. 2016 Feb 22;9(4):341-351. doi: 10.1016/j.jcin.2015.10.039. Epub 2016 Jan 20.

DOI:10.1016/j.jcin.2015.10.039
PMID:26803418
Abstract

OBJECTIVES

The purpose of this study was to examine the temporal trends in demographics, clinical characteristics, management strategies, and in-hospital outcomes in patients with acute myocardial infarction complicated by cardiogenic shock (CS-AMI) who underwent percutaneous coronary intervention (PCI) from the Cath-PCI Registry (2005 to 2013).

BACKGROUND

The authors examined contemporary use and outcomes of PCI in patients with CS-AMI.

METHODS

The authors used the Cath-PCI Registry to evaluate 56,497 patients (January 2005 to December 2013) undergoing PCI for CS-AMI. Temporal trends in clinical variables and outcomes were assessed.

RESULTS

Compared with cases performed from 2005 to 2006, CS-AMI patients receiving PCI from 2011 to 2013 were more likely to have diabetes, hypertension, dyslipidemia, previous PCI, dialysis, but less likely to have chronic lung disease, peripheral vascular disease, or heart failure within 2 weeks (p < 0.01). Between 2005 and 2006 to 2011 and 2013, intra-aortic balloon pump use decreased (49.5% to 44.9%; p < 0.01), drug-eluting stent use declined (65% to 46%; p < 0.01), and the use of bivalirudin increased (12.6% to 45.6%). Adjusted in-hospital mortality; increased (27.6% in 2005 to 2006 vs. 30.6% in 2011 to 2013, adjusted odds ratio: 1.09, 95% confidence interval: 1.005 to .173; p = 0.04) for patients who were managed with an early invasive strategy (<24 h from symptoms).

CONCLUSIONS

Our study shows that despite the evolution of medical technology and use of contemporary therapeutic measures, in-hospital mortality in CS-AMI patients who are managed invasively continues to rise. Additional research and targeted efforts are indicated to improve outcomes in this high-risk cohort.

摘要

目的

本研究旨在探讨2005年至2013年期间,接受经皮冠状动脉介入治疗(PCI)的急性心肌梗死合并心源性休克(CS-AMI)患者在人口统计学、临床特征、管理策略及住院结局方面的时间趋势。

背景

作者研究了当代CS-AMI患者PCI的使用情况及结局。

方法

作者利用Cath-PCI注册研究评估了56497例2005年1月至2013年12月期间接受PCI治疗的CS-AMI患者。评估临床变量及结局的时间趋势。

结果

与2005年至2006年进行的病例相比,2011年至2013年接受PCI的CS-AMI患者更易患糖尿病、高血压、血脂异常、既往接受过PCI、透析,但在2周内患慢性肺病、外周血管疾病或心力衰竭的可能性较小(p<0.01)。在2005年至2006年至2011年至2013年期间,主动脉内球囊泵的使用减少(49.5%至44.9%;p<0.01),药物洗脱支架的使用下降(65%至46%;p<0.01),比伐卢定的使用增加(12.6%至45.6%)。对于采用早期侵入性策略(症状出现后<24小时)治疗的患者,调整后的住院死亡率有所增加(2005年至2006年为27.6%,2011年至2013年为30.6%,调整后的优势比:1.09,95%置信区间:1.005至1.173;p=0.04)。

结论

我们的研究表明,尽管医疗技术有所发展且采用了当代治疗措施,但侵入性治疗的CS-AMI患者的住院死亡率仍在上升。需要进一步的研究和针对性努力以改善这一高危人群的结局。

相似文献

1
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry.急性心肌梗死合并心源性休克患者接受经皮冠状动脉介入治疗的时间趋势和结局:来自心脏导管介入注册研究的报告
JACC Cardiovasc Interv. 2016 Feb 22;9(4):341-351. doi: 10.1016/j.jcin.2015.10.039. Epub 2016 Jan 20.
2
Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.未选择患者的心源性休克合并急性 ST 段抬高型心肌梗死的管理和预后预测因素:不来梅 STEMI 注册研究结果。
Clin Res Cardiol. 2018 May;107(5):371-379. doi: 10.1007/s00392-017-1192-0. Epub 2017 Dec 11.
3
Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.美国急性心肌梗死合并非梗死相关心原性休克患者应用机械循环支持治疗的趋势和院内死亡率。
Clin Res Cardiol. 2018 Apr;107(4):287-303. doi: 10.1007/s00392-017-1182-2. Epub 2017 Nov 13.
4
Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.急性心肌梗死合并心源性休克患者使用机械循环支持的当代趋势。
Open Heart. 2020 Mar 4;7(1):e001214. doi: 10.1136/openhrt-2019-001214. eCollection 2020.
5
Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock.急性心肌梗死合并心源性休克患者死亡的相关因素。
Cardiovasc Revasc Med. 2014 Jan;15(1):13-7. doi: 10.1016/j.carrev.2013.08.012.
6
Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018.2009-2018 年美国急性心肌梗死伴心原性休克多支冠状动脉疾病患者的血运重建实践和结局。
JAMA Intern Med. 2020 Oct 1;180(10):1317-1327. doi: 10.1001/jamainternmed.2020.3276.
7
Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.血管内微型轴流左心室辅助装置与主动脉内球囊泵在急性心肌梗死合并心源性休克患者中的应用与院内死亡率和大出血的关系。
JAMA. 2020 Feb 25;323(8):734-745. doi: 10.1001/jama.2020.0254.
8
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.接受经皮冠状动脉介入治疗患者急性肾损伤的当代发病率、预测因素及预后:来自国家心血管数据注册库(NCDR)导管介入治疗注册研究的见解
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.
9
Temporal trends and in-hospital outcomes of primary percutaneous coronary intervention in nonagenarians with ST-segment elevation myocardial infarction.非agenarians(可能有误,推测为非agenarian即非九十岁老人)ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗的时间趋势及院内结局
Korean J Intern Med. 2015 Nov;30(6):821-8. doi: 10.3904/kjim.2015.30.6.821. Epub 2015 Oct 30.
10
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.

引用本文的文献

1
Cardiogenic Shock With Acute Myocardial Infarction Among Older Adults in the United States.美国老年人中心源性休克合并急性心肌梗死的情况
JACC Adv. 2025 Aug 19;4(9):102078. doi: 10.1016/j.jacadv.2025.102078.
2
Mortality trends related to cardiogenic shock in heart failure patients aged 25 and older across the United States: A study utilizing the CDC WONDER database from 1999 to 2023.美国25岁及以上心力衰竭患者心源性休克相关的死亡率趋势:一项利用1999年至2023年疾病控制与预防中心(CDC)WONDER数据库的研究。
Int J Cardiol Heart Vasc. 2025 Jun 26;59:101732. doi: 10.1016/j.ijcha.2025.101732. eCollection 2025 Aug.
3
Foreword.
前言。
Interv Cardiol. 2017 May;12(Suppl 1):4-22. doi: 10.15420/icr.2017.12.1.S1.
4
In-Hospital Mortality Predictors in Patients with Acute Myocardial Infarction and Cardiogenic Shock Using Intra-Aortic Balloon Pump.使用主动脉内球囊反搏治疗急性心肌梗死合并心源性休克患者的院内死亡率预测因素
Arq Bras Cardiol. 2025 Feb;122(2):e20230496. doi: 10.36660/abc.20230496.
5
The Role of Impella in Cardiogenic Shock Complicated by an Acute Myocardial Infarction: A Meta-Analysis.Impella在急性心肌梗死并发心源性休克中的作用:一项荟萃分析。
J Clin Med. 2025 Jan 18;14(2):611. doi: 10.3390/jcm14020611.
6
Venoarterial Membrane Oxygenation in Cardiogenic Shock Complicated from an Acute Myocardial Infarction: An Overview and Comprehensive Meta-Analysis.急性心肌梗死并发心源性休克的静脉-动脉膜肺氧合:综述与综合荟萃分析
Biomedicines. 2025 Jan 20;13(1):237. doi: 10.3390/biomedicines13010237.
7
The Effect of Percutaneous Coronary Intervention on Patients with Acute Myocardial Infarction and Cardiogenic Shock Supported by Extracorporeal Membrane Oxygenation.经皮冠状动脉介入治疗对体外膜肺氧合支持下的急性心肌梗死合并心源性休克患者的影响。
Rev Cardiovasc Med. 2024 Dec 23;25(12):449. doi: 10.31083/j.rcm2512449. eCollection 2024 Dec.
8
Cardiogenic Shock: Protocols, Teams, Centers, and Networks.心源性休克:方案、团队、中心及网络
US Cardiol. 2021 Oct 20;15:e18. doi: 10.15420/usc.2021.10. eCollection 2021.
9
A CLINICAL PREDICTION MODEL FOR SHORT-TERM PROGNOSIS IN PATIENTS WITH NON-ACUTE MYOCARDIAL INFARCTION-RELATED CARDIOGENIC SHOCK.非急性心肌梗死相关性心源性休克患者短期预后的临床预测模型
Shock. 2025 May 1;63(5):706-713. doi: 10.1097/SHK.0000000000002535. Epub 2024 Dec 10.
10
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial.坎格雷洛与替格瑞洛碾碎片在急性心肌梗死合并心原性休克患者中的应用:随机、双盲 DAPT-SHOCK-AMI 试验的原理和设计。
EuroIntervention. 2024 Oct 21;20(20):e1309-e1318. doi: 10.4244/EIJ-D-24-00203.